+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sciatica Treatment Market 2019-2023 - Product Image

Global Sciatica Treatment Market 2019-2023

  • ID: 4761572
  • Report
  • Region: Global
  • 119 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • MORE
Sciatica is often confused with general back pain. Sciatica can cause long-term pain in the lower back if the condition is left untreated. Hence, various government and non-governmental organizations are initiating certain programs to increase awareness among people about the condition and avoid delay in diagnosis. For instance, Ortholnfo, the patient education site of the American Academy of Orthopaedic Surgeons (AAOS), is providing awareness about sciatica, through articles, videos, and animations, in the US. Similarly, initiative from different countries are providing comprehensive and relevant health information related to various hearth-related problems, including sciatica. Such increasing awareness programs help patients to know about the disease and available safe treatment options, which are expected to drive market growth during the forecast period. The analysts have predicted that the sciatica treatment market will register a close to 8% by 2023.

Market Overview

Growing prevalence of risk factors for sciatica

Although sciatica occurs more commonly due to spinal cord injuries. It also occurs due to disease conditions such as lumbar spinal stenosis, osteoarthritis, spondylolisthesis, and muscle spasms. Hence, an increase in the number of patients with these diseases may increase the chances of development of sciatica. This, in turn, is expected to aid in the use of available and anticipated treatments and drive the growth of the global sciatica treatment market during the forecast period.

Lack of approved treatments

Most of the patients benefit from this combination of treatment methods such as epidural injections of corticosteroids, physiotherapy, and bracing. However, there is no approved treatment for sciatica. Therefore, the lack of approved treatments for sciatica is expected to hamper the growth of the global sciatica treatment market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the sciatica treatment market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be highly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Non-surgical treatment - Market size and forecast 2018-2023
  • Surgical treatment - Market size and forecast 2018-2023
  • Market opportunity by type
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Phase III pipeline molecules: Overview
Exhibit 18: Type - Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Non-surgical treatment - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Non-surgical treatment - Year-over-year growth 2019-2023 (%)
Exhibit 22: Surgical treatment - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Surgical treatment - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in North America
Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in Europe
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Asia
Exhibit 37: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in ROW
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Bayer AG - Vendor overview
Exhibit 49: Bayer AG - Business segments
Exhibit 50: Bayer AG - Organizational developments
Exhibit 51: Bayer AG - Geographic focus
Exhibit 52: Bayer AG - Segment focus
Exhibit 53: Bayer AG - Key offerings
Exhibit 54: Bayer AG - Key customers
Exhibit 55: Johnson & Johnson Services, Inc. - Vendor overview
Exhibit 56: Johnson & Johnson Services, Inc. - Business segments
Exhibit 57: Johnson & Johnson Services, Inc. - Organizational developments
Exhibit 58: Johnson & Johnson Services, Inc. - Geographic focus
Exhibit 59: Johnson & Johnson Services, Inc. - Segment focus
Exhibit 60: Johnson & Johnson Services, Inc. - Key offerings
Exhibit 61: Johnson & Johnson Services, Inc. - Key customers
Exhibit 62: Novartis AG - Vendor overview
Exhibit 63: Novartis AG - Business segments
Exhibit 64: Novartis AG - Organizational developments
Exhibit 65: Novartis AG - Geographic focus
Exhibit 66: Novartis AG - Segment focus
Exhibit 67: Novartis AG - Key offerings
Exhibit 68: Novartis AG - Key customers
Exhibit 69: Pfizer Inc. - Vendor overview
Exhibit 70: Pfizer Inc. - Business segments
Exhibit 71: Pfizer Inc. - Organizational developments
Exhibit 72: Pfizer Inc. - Geographic focus
Exhibit 73: Pfizer Inc. - Segment focus
Exhibit 74: Pfizer Inc. - Key offerings
Exhibit 75: Pfizer Inc. - Key customers
Exhibit 76: Teva Pharmaceutical Industries Ltd. - Vendor overview
Exhibit 77: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 78: Teva Pharmaceutical Industries Ltd. - Organizational developments
Exhibit 79: Teva Pharmaceutical Industries Ltd. - Geographic focus
Exhibit 80: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 81: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 82: Teva Pharmaceutical Industries Ltd. - Key customers
Exhibit 83: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • MORE
Global Sciatica Treatment Market 2019-2023

The analyst recognizes the following companies as the key players in the global sciatica treatment market: Bayer AG, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the development of clonidine micropellet epidural injections.”

According to the report, one of the major drivers for this market is the regulatory support for pipeline drugs.

Further, the report states that one of the major factors hindering the growth of this market is the failures of drugs ion the clinical stages of development are expected to pose a challenge to the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll